Clinical Outcomes After Personalized Dosimetry for 90Y Radioembolization of Advanced Hepatocellular Carcinoma: Defining the Role of a Device in a Pharma-Centric Landscape. - Soulen MC; Rilling WS (Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2024)